(Q44920531)

7 December 2017

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection (English)

1 reference

7 December 2017

0 references

0 references

3

Nathan Clumeck

1 reference

7 December 2017

6

Julio Montaner

1 reference

7 December 2017

7

Mark S Sulkowski

1 reference

7 December 2017

10

David L Thomas

1 reference

7 December 2017

2

Eduardo Lissen

1 reference

7 December 2017

Richard K Sterling

1

1 reference

7 December 2017

Ricard Sola

4

1 reference

7 December 2017

Mendes Cassia Correa

5

1 reference

7 December 2017

Francesca J Torriani

8

1 reference

7 December 2017

Doug T Dieterich

9

1 reference

7 December 2017

Diethelm Messinger

11

1 reference

7 December 2017

Mark Nelson

12

1 reference

7 December 2017

APRICOT Clinical Investigators

13

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

7 December 2017

1 reference

7 December 2017

43

1 reference

7 December 2017

6

1 reference

7 December 2017

1317-1325

1 reference

Hepatitis C in the HIV-Infected Person

7 December 2017

1 reference

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

7 January 2021

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

1 reference

7 January 2021

Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection

1 reference

7 January 2021

Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy

1 reference

7 January 2021

Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study

1 reference

7 January 2021

Impact of highly active antiretroviral therapy on the spectrum of liver disease in HCV-HIV coinfection

1 reference

7 January 2021

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

1 reference

7 January 2021

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

1 reference

7 January 2021

Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus

1 reference

7 January 2021

A comparison of fibrosis progression in chronic liver diseases

1 reference

7 January 2021

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

1 reference

7 January 2021

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

1 reference

7 January 2021

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

1 reference

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients.

1 reference

7 January 2021

AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection

1 reference

7 January 2021

1 reference

7 January 2021

A 21-year experience with major hemorrhage after percutaneous liver biopsy

1 reference

7 January 2021

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

1 reference

7 January 2021

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

1 reference

7 January 2021

Sampling variability of liver fibrosis in chronic hepatitis C.

1 reference

7 January 2021

Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection

1 reference

7 January 2021

Assessing fibrosis without a liver biopsy: are we there yet?

1 reference

7 January 2021

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

7 January 2021

Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients

1 reference

7 January 2021

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.

1 reference

7 January 2021

Serum markers detect the presence of liver fibrosis: a cohort study.

1 reference

7 January 2021

Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.

1 reference

7 January 2021

Noninvasive prediction of fibrosis in patients with chronic hepatitis C

1 reference

7 January 2021

Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.

1 reference

7 January 2021

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

1 reference

7 January 2021

Validation of a simple predictive model for the identification of mild hepatic fibrosis in chronic hepatitis C patients

1 reference

7 January 2021

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

7 January 2021

Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index

1 reference

7 January 2021

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

1 reference

7 January 2021

Role of liver biopsy in the evaluation of hepatitis C virus infection in HIV coinfection

1 reference

7 January 2021

Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index

1 reference

7 January 2021

Noninvasive markers of hepatic fibrosis: are they ready for prime time in the management of HIV/HCV co-infected patients?

1 reference

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

7 January 2021

Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.

1 reference

7 January 2021

A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African Americans

1 reference

7 January 2021

Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups

1 reference

7 January 2021

Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells

1 reference

7 January 2021

Serum Activity of Mitochondrial Aspartate Aminotransferase: A Sensitive Marker of Alcoholism With or Without Alcoholic Hepatitis

1 reference

7 January 2021

The clinical spectrum of hepatitis C virus in HIV coinfection

1 reference

7 January 2021

The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21178

1 reference

7 December 2017

1 reference